Your browser doesn't support javascript.
loading
Current practice and perspectives in CRO oversight based on a survey performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).
Hennig, Michael; Hundt, Ferdinand; Busta, Susanne; Mikus, Stefan; Sanden, Per-Holger; Sörgel, Andrea; Ruppert, Thorsten.
Affiliation
  • Hennig M; GlaxoSmithKline GmbH & Co. KG, Munich, Germany.
  • Hundt F; Doc-Dog-Consulting, Berlin, Germany.
  • Busta S; Bristol-Myers Squibb, Munich, Germany.
  • Mikus S; Pfizer Pharma GmbH, Berlin, Germany.
  • Sanden PH; Merck KGaA, Darmstadt, Germany.
  • Sörgel A; MSD Sharp & Dohme GmbH, Munich, Germany.
  • Ruppert T; vfa, Berlin, Germany.
Ger Med Sci ; 15: Doc02, 2017.
Article in En | MEDLINE | ID: mdl-28163667
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomedical Research / Contracts / Drug Industry Type of study: Clinical_trials / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Ger Med Sci Journal subject: MEDICINA Year: 2017 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomedical Research / Contracts / Drug Industry Type of study: Clinical_trials / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Ger Med Sci Journal subject: MEDICINA Year: 2017 Document type: Article Affiliation country: Country of publication: